Poland
Barr has both manufacturing and R&D facilities in Poland.
The Polish pharmaceutical market is the second largest in Central and Eastern Europe and relies heavily on generic drugs,
though it remains a branded market with emphasis on product promotion. Sumamed is the Company's largest selling product in Poland, where Barr also has a strong portfolio of over-the-counter drugs.
At the end of 2007, the Company ranked fourth
in this generic market. As a result of high patient co-payments, competition among pharmacies and general economic growth,
the market is highly competitive and is expected to grow.
Product Guide 
